CNSP
Price
$0.88
Change
+$0.04 (+4.76%)
Updated
Jun 27 closing price
Capitalization
4.8M
PTGX
Price
$55.69
Change
+$0.47 (+0.85%)
Updated
Jun 27 closing price
Capitalization
3.45B
31 days until earnings call
Interact to see
Advertisement

CNSP vs PTGX

Header iconCNSP vs PTGX Comparison
Open Charts CNSP vs PTGXBanner chart's image
CNS Pharmaceuticals
Price$0.88
Change+$0.04 (+4.76%)
Volume$240.31K
Capitalization4.8M
Protagonist Therapeutics
Price$55.69
Change+$0.47 (+0.85%)
Volume$1.55M
Capitalization3.45B
CNSP vs PTGX Comparison Chart in %
Loading...
CNSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PTGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CNSP vs. PTGX commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNSP is a Buy and PTGX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (CNSP: $0.88 vs. PTGX: $55.69)
Brand notoriety: CNSP and PTGX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CNSP: 11% vs. PTGX: 172%
Market capitalization -- CNSP: $4.8M vs. PTGX: $3.45B
CNSP [@Biotechnology] is valued at $4.8M. PTGX’s [@Biotechnology] market capitalization is $3.45B. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNSP’s FA Score shows that 1 FA rating(s) are green whilePTGX’s FA Score has 1 green FA rating(s).

  • CNSP’s FA Score: 1 green, 4 red.
  • PTGX’s FA Score: 1 green, 4 red.
According to our system of comparison, PTGX is a better buy in the long-term than CNSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNSP’s TA Score shows that 5 TA indicator(s) are bullish while PTGX’s TA Score has 5 bullish TA indicator(s).

  • CNSP’s TA Score: 5 bullish, 3 bearish.
  • PTGX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, CNSP is a better buy in the short-term than PTGX.

Price Growth

CNSP (@Biotechnology) experienced а +14.01% price change this week, while PTGX (@Biotechnology) price change was +4.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

PTGX is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PTGX($3.45B) has a higher market cap than CNSP($4.8M). PTGX has higher P/E ratio than CNSP: PTGX (71.40) vs CNSP (0.00). PTGX YTD gains are higher at: 44.275 vs. CNSP (-85.399). PTGX has higher annual earnings (EBITDA): 30.1M vs. CNSP (-15.6M). PTGX has more cash in the bank: 574M vs. CNSP (13M). CNSP has less debt than PTGX: CNSP (211K) vs PTGX (11.4M). PTGX has higher revenues than CNSP: PTGX (208M) vs CNSP (0).
CNSPPTGXCNSP / PTGX
Capitalization4.8M3.45B0%
EBITDA-15.6M30.1M-52%
Gain YTD-85.39944.275-193%
P/E Ratio0.0071.400%
Revenue0208M-
Total Cash13M574M2%
Total Debt211K11.4M2%
FUNDAMENTALS RATINGS
PTGX: Fundamental Ratings
PTGX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
PROFIT vs RISK RATING
1..100
44
SMR RATING
1..100
55
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CNSPPTGX
RSI
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
64%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
81%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 3 days ago
78%
MACD
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
82%
Advances
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
78%
Declines
ODDS (%)
Bearish Trend 17 days ago
90%
Bearish Trend 10 days ago
77%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
73%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
CNSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PTGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EXAS53.671.86
+3.59%
Exact Sciences Corp
MTW12.270.03
+0.25%
Manitowoc Company (The)
MAYS39.75-0.45
-1.12%
J. W. Mays
MBRX0.31-0.01
-3.04%
Moleculin Biotech
RDW16.12-0.84
-4.95%
Redwire Corp

CNSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNSP has been loosely correlated with BRCTF. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if CNSP jumps, then BRCTF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNSP
1D Price
Change %
CNSP100%
+5.02%
BRCTF - CNSP
37%
Loosely correlated
N/A
PTGX - CNSP
27%
Poorly correlated
+0.86%
NRIX - CNSP
26%
Poorly correlated
+0.17%
MGNX - CNSP
26%
Poorly correlated
-6.30%
VIGL - CNSP
25%
Poorly correlated
N/A
More

PTGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PTGX has been closely correlated with BIESF. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if PTGX jumps, then BIESF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTGX
1D Price
Change %
PTGX100%
+0.86%
BIESF - PTGX
67%
Closely correlated
N/A
MLYS - PTGX
51%
Loosely correlated
-2.07%
TRVI - PTGX
44%
Loosely correlated
-0.71%
FULC - PTGX
38%
Loosely correlated
-3.79%
MDGL - PTGX
35%
Loosely correlated
N/A
More